Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation
Open Access
- 26 November 2013
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 110 (50), 20200-20205
- https://doi.org/10.1073/pnas.1313654110
Abstract
The association between lymphopenia and autoimmunity is recognized, but the underlying mechanisms are poorly understood and have not been studied systematically in humans. People with multiple sclerosis treated with the lymphocyte-depleting monoclonal antibody alemtuzumab offer a unique opportunity to study this phenomenon; one in three people develops clinical autoimmunity, and one in three people develops asymptomatic autoantibodies after treatment. Here, we show that T-cell recovery after alemtuzumab is driven by homeostatic proliferation, leading to the generation of chronically activated (CD28−CD57+), highly proliferative (Ki67+), oligoclonal, memory-like CD4 and CD8 T cells (CCR7−CD45RA− or CCR7−CD45RA+) capable of producing proinflammatory cytokines. Individuals who develop autoimmunity after treatment are no more lymphopenic than their nonautoimmune counterparts, but they show reduced thymopoiesis and generate a more restricted T-cell repertoire. Taken together, these findings demonstrate that homeostatic proliferation drives lymphopenia-associated autoimmunity in humans.Keywords
This publication has 48 references indexed in Scilit:
- Helios Expression Is a Marker of T Cell Activation and ProliferationPLOS ONE, 2011
- CD8+ CD28− and CD8+ CD57+ T cells and their role in health and diseaseImmunology, 2011
- Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory CellsThe Journal of Immunology, 2010
- T Cell Receptor-Dependent Regulation of Lipid Rafts Controls Naive CD8+ T Cell HomeostasisImmunity, 2010
- Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cellsBlood, 2009
- Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse modelImmunology, 2009
- IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)JCI Insight, 2009
- Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cellsNature Immunology, 2009
- Memory-like CD8+and CD4+T cells cooperate to break peripheral tolerance under lymphopenic conditionsProceedings of the National Academy of Sciences of the United States of America, 2008
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionThe Journal of Experimental Medicine, 2007